Ask AI

Library

Updates

Loading...

Table of contents

Expand All Topics

Mitral stenosis

Background

Overview

Definition
MS is a form of structural heart disease characterized by obstruction to diastolic flow of blood across the mitral valve, from the left atrium to the left ventricle.
1
Pathophysiology
The etiology of MS is rheumatic disease in over 99% of patients. Other rare causes of MS include congenital malformed valves, active infective endocarditis, massive annular calcium, and metabolic or enzymatic abnormalities.
2
Epidemiology
The prevalence of MS in the US is estimated at 100 patients per 100,000 population.
1
Disease course
Clinical manifestations of MS often occur when there is an increased demand for cardiac output, and thus more transmitral flow, which causes elevation of the resting transmitral gradient. This may occur with pregnancy, fever, arrhythmias, infection, thyrotoxicosis, or during exercise. MS is associated with a significantly increased risk of AF.
3
Prognosis and risk of recurrence
In patients with degenerative MS, 1- and 5-year survival rates are estimated at 78% and 47%, respectively. Mortality is correlated with echocardiographic severity grades.
4

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of mitral stenosis are prepared by our editorial team based on guidelines from the Society of Cardiovascular Computed Tomography (SCCT/SVM/SCMR/SCA/AHA/ASNC/HRS/ACC/ACS 2024), the European Society of Cardiology (ESC 2022), the European Society of Cardiology (ESC/EACTS 2022,2021), the American Heart Association (AHA/ACC 2021), the Canadian Cardiovascular Society (CCS 2018), and the Cardiac Society ...
Show more